Form 4: United Therapeutics Director Tommy G. Thompson Reports Share Transactions

Director Tommy G. Thompson reports acquisition and disposal of United Therapeutics Corp shares, including transactions involving share tracking awards.

Summary

• On March 6, 2024, Tommy G. Thompson, a director of United Therapeutics Corp, reported transactions involving the company's common stock and share tracking awards.
• Thompson acquired 2,000 shares of common stock at $88.03 through the exercise of share tracking awards.
• Simultaneously, Thompson disposed of 2,000 shares of common stock at $236.97.
• Following these transactions, Thompson directly owns 8,480 shares of common stock.
• Thompson also indirectly owns 5,800 shares through a Family LLC and 8,200 shares through a Trust.
• The reported transactions also involved share tracking awards, which are non-dilutive cash-settled stock appreciation rights.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.

Key Dates